Anderson is an assistant professor of urology at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Management of hormone-naïve oligometastatic prostate cancer
Growing evidence supports the existence of an intermediate metastatic disease state.
UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC
Enrollment complete for phase 3 UTOPIA trial in LG-IR-NMIBC
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
FDA and EMA authorize phase 3 trial of masitinib for mCRPC